Private Market View

Vo Health

New Haven, CT · Founded 2025 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include 2048 Ventures, Better Ventures.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 2 names
  • ·Watchlist + deal alerts for Vo Health
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Vo Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Vo Health

Developer of advanced biomarker technology intended to evaluate health span and performance for precision health purposes. The company uses proteomic profiling, molecular data integration, and AI-driven analytics to deliver personalized insights into longevity and physiological resilience, enabling healthcare providers and researchers to adopt preventive strategies and optimize individual health outcomes.

Sector
Healthcare
HQ
New Haven, CT, United States
Founded
2025
Ownership
Privately Held (backing)
PA Mark — not yet priced

Vo Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Vo Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Vo Health in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.